White label ELPA - ClinicalTrials.eu

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Recruiting

3 1
Investigated diseases:
- Bronchiectasis
Investigated drugs:
- Bi 1291583
+16
Study of telisotuzumab adizutecan with osimertinib as first treatment for adults with advanced or metastatic EGFR-mutated non-small cell lung cancer

Recruiting

4 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases

Recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Atacicept
Study of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care

Recruiting

4 1 1 1
Investigated diseases:
- Renal transplant
Investigated drugs:
Comparing piperacillin-tazobactam and meropenem for treating bloodstream infections caused by cephalosporin-resistant bacteria in adult patients

Recruiting

3 1 1 1
Investigated diseases:
- Bacteraemia
Investigated drugs:
Study of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden

Recruiting

3 1 1 1
Investigated diseases:
- Gastroenteropancreatic neuroendocrine tumour disease
Investigated drugs:
+1
Study of intramuscular methylprednisolone acetate to treat pain in patients with hand osteoarthritis

Recruiting

3 1 1
Investigated diseases:
- Osteoarthritis
Investigated drugs:
- Methylprednisolone Acetate
- Sodium Chloride
Study of baricitinib versus placebo for treating polymyalgia rheumatica in adult patients

Recruiting

3 1 1
Investigated diseases:
- Polymyalgia rheumatica
Investigated drugs:
- Baricitinib
Study of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia

Recruiting

3 1
Investigated diseases:
- Hypertriglyceridaemia
Investigated drugs:
- Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
+6
Study of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies